highly significantp -value < 0.001
New patients had a 5-year survival rate of 67%, while old patients had a rate of 50%, and this difference was highly significant ( p -value < 0.001) ( Table 3 ).
New patients had a 5-year survival rate of 67%, while old patients had a rate of 50%, and this difference was highly significant ( p -value < 0.001) ( Table 3 ).
Stage-wise 5-year survival rates showed a decreasing trend from stage I (83%) to stage IV (55%).